Monitoring of deferiprone involves regular blood tests to assess blood cell counts and liver function. Monitoring ensures early detection of hematological abnormalities and liver toxicity, allowing for timely intervention. Patients on deferiprone should have their absolute neutrophil count checked weekly to prevent agranulocytosis. Liver function tests are also recommended periodically.
